RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,140,359 | -2.9% | 26,318 | +3.1% | 0.00% | -20.0% |
| Q4 2023 | $1,173,936 | +99.7% | 25,537 | -0.4% | 0.01% | +25.0% |
| Q3 2023 | $587,797 | +44.1% | 25,640 | +3.7% | 0.00% | +100.0% |
| Q2 2023 | $407,781 | +61.8% | 24,729 | +13.1% | 0.00% | +100.0% |
| Q1 2022 | $252,000 | +7.7% | 21,871 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $234,000 | -25.7% | 23,411 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $315,000 | -34.8% | 24,111 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $483,000 | +2.3% | 24,684 | +11.1% | 0.00% | 0.0% |
| Q1 2021 | $472,000 | -18.8% | 22,212 | +13.7% | 0.00% | 0.0% |
| Q4 2020 | $581,000 | +33.3% | 19,542 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $436,000 | -4.8% | 20,101 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $458,000 | +73.5% | 20,559 | +18.5% | 0.00% | +100.0% |
| Q1 2020 | $264,000 | -37.3% | 17,350 | -5.5% | 0.00% | -50.0% |
| Q4 2019 | $421,000 | +34.5% | 18,353 | +26.5% | 0.00% | +100.0% |
| Q3 2019 | $313,000 | -2.5% | 14,507 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $321,000 | +20.7% | 14,608 | +50.5% | 0.00% | 0.0% |
| Q1 2019 | $266,000 | -1.1% | 9,707 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $269,000 | -8.8% | 10,021 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $295,000 | +18.0% | 10,098 | +26.5% | 0.00% | 0.0% |
| Q2 2018 | $250,000 | +138.1% | 7,984 | +51.6% | 0.00% | – |
| Q1 2018 | $105,000 | -34.8% | 5,265 | -5.1% | 0.00% | -100.0% |
| Q4 2017 | $161,000 | – | 5,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
| NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
| Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
| RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
| Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
| Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
| Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
| HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
| Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
| GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |